NCT01191684View on ClinicalTrials.gov

Vaccine Therapy in Treating Patients With Colorectal, Stomach, or Pancreatic Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

August 31, 2013

Study Completion Date

August 31, 2013

Conditions
Recurrent Colon CancerRecurrent Gastric CancerRecurrent Pancreatic CancerRecurrent Rectal CancerStage III Colon CancerStage III Gastric CancerStage III Pancreatic CancerStage III Rectal CancerStage IV Colon CancerStage IV Gastric CancerStage IV Pancreatic CancerStage IV Rectal Cancer
Interventions
OTHER

laboratory biomarker analysis

Correlative studies

OTHER

enzyme-linked immunosorbent assay

Correlative studies

OTHER

flow cytometry

Correlative studies

OTHER

immunoenzyme technique

Correlative studies

BIOLOGICAL

modified vaccinia virus ankara vaccine expressing p53

Given SC

Trial Locations (1)

91010

City of Hope Medical Center, Duarte

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

City of Hope Medical Center

OTHER

NCT01191684 - Vaccine Therapy in Treating Patients With Colorectal, Stomach, or Pancreatic Cancer | Biotech Hunter | Biotech Hunter